Health-care investment firm Deerfield Management Co. is moving to convert a Manhattan building into a drug-research laboratory and office space for $635 million, a promising sign that long-running efforts to turn New York City into a hub for the biotech industry are taking root. New York-based Deerfield recently bought […]
Click here to view original web page at www.wsj.com
Author
Biotech Metropolitan 
